1. Home
  2. PHAR vs MNTK Comparison

PHAR vs MNTK Comparison

Compare PHAR & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • MNTK
  • Stock Information
  • Founded
  • PHAR 1988
  • MNTK 1980
  • Country
  • PHAR Netherlands
  • MNTK United States
  • Employees
  • PHAR N/A
  • MNTK N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • MNTK Natural Gas Distribution
  • Sector
  • PHAR Health Care
  • MNTK Utilities
  • Exchange
  • PHAR Nasdaq
  • MNTK Nasdaq
  • Market Cap
  • PHAR 618.3M
  • MNTK 622.2M
  • IPO Year
  • PHAR N/A
  • MNTK 2021
  • Fundamental
  • Price
  • PHAR $8.20
  • MNTK $4.22
  • Analyst Decision
  • PHAR Strong Buy
  • MNTK Hold
  • Analyst Count
  • PHAR 3
  • MNTK 2
  • Target Price
  • PHAR $27.00
  • MNTK $6.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • MNTK 156.6K
  • Earning Date
  • PHAR 03-13-2025
  • MNTK 03-13-2025
  • Dividend Yield
  • PHAR N/A
  • MNTK N/A
  • EPS Growth
  • PHAR N/A
  • MNTK 42.11
  • EPS
  • PHAR N/A
  • MNTK 0.16
  • Revenue
  • PHAR $285,745,000.00
  • MNTK $194,849,000.00
  • Revenue This Year
  • PHAR $20.08
  • MNTK $21.28
  • Revenue Next Year
  • PHAR $9.22
  • MNTK $31.59
  • P/E Ratio
  • PHAR N/A
  • MNTK $26.27
  • Revenue Growth
  • PHAR 30.64
  • MNTK 9.63
  • 52 Week Low
  • PHAR $6.65
  • MNTK $3.38
  • 52 Week High
  • PHAR $13.20
  • MNTK $6.88
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 36.29
  • MNTK 47.56
  • Support Level
  • PHAR $8.49
  • MNTK $4.01
  • Resistance Level
  • PHAR $9.35
  • MNTK $4.34
  • Average True Range (ATR)
  • PHAR 0.55
  • MNTK 0.22
  • MACD
  • PHAR -0.17
  • MNTK -0.02
  • Stochastic Oscillator
  • PHAR 12.14
  • MNTK 20.63

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

Share on Social Networks: